Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-28

Clinical Trial Update: Multicentre Medical-economic Study Evaluating the Efficacy of Adding ZOlédronique Acid to STERéotaxique Radiotherapy in the Treatment of Vertebral Metastases [Phase 3]

View source ↗

Summary

Phase 3 multicenter study evaluating adding zoledronic acid to stereotactic radiotherapy for vertebral metastases; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZOlédronique Acid (zoledronic acid)

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Vertebral Metastasis | Phase 3 | Status: UNKNOWN